Perspective Therapeutics
(AMEX:CATX)
$1.61
0.08[5.23%]
At close: May 17
$1.61
0[0.00%]
After Hours: 4:14PM EDT
Q1 2024 Earnings were released on Wed May 15th, before the market open
Consensus Rating1
Buy
Highest Price Target1
$3.00
Lowest Price Target1
$1.40
Consensus Price Target1
$1.63

Perspective Therapeutics Stock (AMEX:CATX), Analyst Ratings, Price Targets, Predictions

Perspective Therapeutics Inc has a consensus price target of $1.63, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from Jones Trading, RBC Capital, and Cantor Fitzgerald on May 16, 2024, May 14, 2024, and May 9, 2024. With an average price target of $1.73 between Jones Trading, RBC Capital, and Cantor Fitzgerald, there's an implied 8.33% upside for Perspective Therapeutics Inc from these 3 analyst ratings.

Analyst Trend
1
Jan
1
Mar
2
Apr
3
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Jones Trading
RBC Capital
Cantor Fitzgerald
B. Riley Securities
Oppenheimer

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Perspective Therapeutics

Buy NowGet Alert
05/16/2024Buy Now37.5%Jones Trading
Justin Walsh
$1.5 → $2.2MaintainsBuyGet Alert
05/14/2024Buy Now87.5%RBC Capital
Gregory Renza
→ $3Initiates → OutperformGet Alert
05/09/2024Buy NowCantor Fitzgerald
Louis Chen
Initiates → OverweightGet Alert
04/09/2024Buy Now6.25%B. Riley Securities
Yuan Zhi
$1.2 → $1.7MaintainsBuyGet Alert
04/01/2024Buy Now-6.25%Oppenheimer
Jeff Jones
$1.2 → $1.5ReiteratesOutperform → OutperformGet Alert
03/19/2024Buy Now-25%Oppenheimer
Jeff Jones
$1.2 → $1.2ReiteratesOutperform → OutperformGet Alert
01/26/2024Buy Now-25%B. Riley Securities
Yuan Zhi
→ $1.2Initiates → BuyGet Alert
11/15/2023Buy Now-12.5%JonesTrading
Justin Walsh
→ $1.4Initiates → BuyGet Alert
05/19/2023Buy Now-25%Oppenheimer
Jeff Jones
$1 → $1.2MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Perspective Therapeutics (CATX)?

A

The latest price target for Perspective Therapeutics (AMEX: CATX) was reported by Jones Trading on May 16, 2024. The analyst firm set a price target for $2.20 expecting CATX to rise to within 12 months (a possible 36.65% upside). 9 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Perspective Therapeutics (CATX)?

A

The latest analyst rating for Perspective Therapeutics (AMEX: CATX) was provided by Jones Trading, and Perspective Therapeutics maintained their buy rating.

Q

When was the last upgrade for Perspective Therapeutics (CATX)?

A

There is no last upgrade for Perspective Therapeutics.

Q

When was the last downgrade for Perspective Therapeutics (CATX)?

A

There is no last downgrade for Perspective Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Perspective Therapeutics (CATX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Perspective Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Perspective Therapeutics was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.

Q

Is the Analyst Rating Perspective Therapeutics (CATX) correct?

A

While ratings are subjective and will change, the latest Perspective Therapeutics (CATX) rating was a maintained with a price target of $1.50 to $2.20. The current price Perspective Therapeutics (CATX) is trading at is $1.61, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch